- Investing.com
Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. The company operates in four segments: Pharmaceutical Wholesale Business, Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales Business, and Other Peripheral Businesses. It sells prescription pharmaceuticals, test reagents, and testing equipment, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP + A, a supporting system for electronic medication history recording with voice recognition; eKenkoshop, web site; Dokoshiru Dengonban, unidentified person with dementia or disabilities information sharing service; ENIFwin Nex-Sus, an Inventory control system for large hospitals; ENIFclub, a membership service; Future ENIF, an information terminal for pharmaceutical ordering; MIZAR, a centralized administration system of pharmacy operations; Byouin-Navi, a Web-portal site for finding hospitals / clinics; and Initial Examination Reservation Service, an online appointment service for first patients. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.
Metrics to compare | 8129 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship8129PeersSector | |
---|---|---|---|---|
P/E Ratio | 15.3x | 13.3x | −0.5x | |
PEG Ratio | 2.46 | 0.37 | 0.00 | |
Price/Book | 1.3x | 1.1x | 2.6x | |
Price / LTM Sales | 0.2x | 0.5x | 3.3x | |
Upside (Analyst Target) | −16.8% | 2.6% | 43.5% | |
Fair Value Upside | Unlock | 25.0% | 6.9% | Unlock |